CareDx (CDNA) Misses Q2 EPS by 1c

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $10.42 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• UBS Upgrades FTC Solar Inc. (FTCI) to Buy
• Nucor projects Q3 2026 earnings above prior year, below estimates